Element Biosciences

Shanghai-based Sequanta Technologies, a leading multi-omics research and clinical service provider, has announced a strategic partnership with US firm Element Biosciences. With the integration of Element’s sequencing platform, the AVITI system, Sequanta is poised to enhance its focus on single-cell applications. The terms of the financial agreement have not been…